Microbot Medical Inc (NASDAQ:MBOT) Expected to Post Earnings of -$0.28 Per Share

Equities analysts expect Microbot Medical Inc (NASDAQ:MBOT) to post ($0.28) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Microbot Medical’s earnings. Microbot Medical reported earnings per share of ($0.44) in the same quarter last year, which would suggest a positive year over year growth rate of 36.4%. The company is expected to report its next quarterly earnings report on Thursday, November 12th.

On average, analysts expect that Microbot Medical will report full year earnings of ($1.14) per share for the current financial year. For the next year, analysts anticipate that the firm will report earnings of ($1.25) per share. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Microbot Medical.

A number of brokerages have recently commented on MBOT. Zacks Investment Research cut Microbot Medical from a “buy” rating to a “hold” rating in a report on Tuesday, September 1st. HC Wainwright raised their price target on Microbot Medical from $19.00 to $20.00 and gave the stock a “buy” rating in a research note on Tuesday, August 18th.

In other Microbot Medical news, Director Yoseph Bornstein sold 15,119 shares of Microbot Medical stock in a transaction on Monday, August 17th. The stock was sold at an average price of $10.19, for a total transaction of $154,062.61. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 8.69% of the company’s stock.

An institutional investor recently raised its position in Microbot Medical stock. BlackRock Inc. grew its stake in Microbot Medical Inc (NASDAQ:MBOT) by 16.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 212,332 shares of the biotechnology company’s stock after acquiring an additional 29,436 shares during the quarter. BlackRock Inc. owned about 2.99% of Microbot Medical worth $1,179,000 at the end of the most recent quarter. 8.21% of the stock is currently owned by institutional investors.

Shares of Microbot Medical stock traded down $0.22 on Tuesday, reaching $7.33. The company had a trading volume of 127,146 shares, compared to its average volume of 557,121. The company has a debt-to-equity ratio of 0.02, a current ratio of 33.81 and a quick ratio of 33.80. The firm’s 50-day moving average price is $7.13 and its two-hundred day moving average price is $6.78. Microbot Medical has a 1 year low of $4.30 and a 1 year high of $20.15.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

Further Reading: Return on Investment (ROI) Defined, Explained

Get a free copy of the Zacks research report on Microbot Medical (MBOT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.